Mon.May 02, 2022

article thumbnail

Plant Host Systems: A Novel Advancement in Protein Expression

Roots Analysis

In the past few years, plants have been gaining a rapid traction, involving genetic modification and expression of new genes in plant host cells. Owing to significant advantages over conventional expression systems, such as low production costs, product safety, and ease of scaling up, plants are being widely recognized as a potential platform for the development and manufacturing of wide range of biopharmaceuticals.

article thumbnail

PMN DTC Engagement Summit

Pharma Marketing Network

Tune in and watch the Pharma Marketing network and industry experts from Otsuka, Biogen, Janssen Pharmaceuticals, and more during part 2 of a 2-part series on engagement. This PMN DTC Engagement Summit focused on DTC engagement throughout the following panels: Marketing at the Speed of Digital: Patient Engagement. Effective Use of Data in DTC Marketing.

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pistoia Alliance calls for more pharma-patient collaboration in early R&D

Outsourcing Pharma

A leader from the life-science organization discusses how collaboration could lead to a broad range of benefits for everyone along the drug discovery pipeline.

52
article thumbnail

FDA says no to two more China-developed cancer drugs

pharmaphorum

The FDA has declined to approve two more cancer therapies developed by drugmakers based in China, in what may be further evidence of a tough line taken by the regulator for drugs tested outside the US. The agency has sent a complete response letter (CRL) to Hutchmed indicating that its application to market multikinase inhibitor surufatinib for advanced neuroendocrine tumours (NETs) had been turned down, and that the company will need to run a new trial to provide evidence the drug works in a US

FDA 52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.